These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1547423)
21. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. Cole SR; Young GP; Byrne D; Guy JR; Morcom J J Med Screen; 2002; 9(4):147-52. PubMed ID: 12518003 [TBL] [Abstract][Full Text] [Related]
22. Results of screening for colorectal carcinoma in the District of Bruntál using the Haemoccult Test in 1985-1988. Zoubek V; Zoubková H Czech Med; 1990; 13(2-3):52-7. PubMed ID: 2245757 [TBL] [Abstract][Full Text] [Related]
23. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Jørgensen OD; Kronborg O; Fenger C Gut; 2002 Jan; 50(1):29-32. PubMed ID: 11772963 [TBL] [Abstract][Full Text] [Related]
24. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy. Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874 [TBL] [Abstract][Full Text] [Related]
25. [Acceptability of the Hemoccult test in general medical practice. Results of a pilot study]. Archambault F; Durand G; Faivre J; Voilquin JP; Archambault P; Riou F; Ageorges P; Archambault ML; Delville JM; Fesneau M Bull Cancer; 1989; 76(10):1071-5. PubMed ID: 2699722 [TBL] [Abstract][Full Text] [Related]
26. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer. Worthley DL; Smith A; Bampton PA; Cole SR; Young GP Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514 [TBL] [Abstract][Full Text] [Related]
27. Blood donor centres can effectively publicise cancer screening. Hart AR; Jestico B; Antill C; Taylor M; Mayberry JF Public Health; 1996 Jul; 110(4):247-9. PubMed ID: 8757707 [TBL] [Abstract][Full Text] [Related]
28. Planning for a possible national colorectal cancer screening programme. Garvican L J Med Screen; 1998; 5(4):187-94. PubMed ID: 9934649 [TBL] [Abstract][Full Text] [Related]
29. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. Towler B; Irwig L; Glasziou P; Kewenter J; Weller D; Silagy C BMJ; 1998 Aug; 317(7158):559-65. PubMed ID: 9721111 [TBL] [Abstract][Full Text] [Related]
30. Psychiatric morbidity and screening for colorectal cancer. Parker MA; Robinson MH; Scholefield JH; Hardcastle JD J Med Screen; 2002; 9(1):7-10. PubMed ID: 11943790 [TBL] [Abstract][Full Text] [Related]
31. Prospective cohort study of compliance with faecal immunochemical tests for colorectal cancer screening in Hong Kong. Wong MC; Ching JY; Lam TY; Luk AK; Hirai HW; Griffiths SM; Chan FK; Sung JJ Prev Med; 2013 Sep; 57(3):227-31. PubMed ID: 23732241 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Coloscreen Self-Test and Haemoccult faecal occult blood tests in the detection of colorectal cancer in symptomatic patients. Pye G; Jackson J; Thomas WM; Hardcastle JD Br J Surg; 1990 Jun; 77(6):630-1. PubMed ID: 2200550 [TBL] [Abstract][Full Text] [Related]
33. Haemoccult screening for colorectal cancer: the effect of dietary restriction on compliance. Robinson MH; Pye G; Thomas WM; Hardcastle JD; Mangham CM Eur J Surg Oncol; 1994 Oct; 20(5):545-8. PubMed ID: 7926056 [TBL] [Abstract][Full Text] [Related]
34. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test. Adamsen S; Kronborg O Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577 [TBL] [Abstract][Full Text] [Related]
35. Randomised trial of compliance with screening for colorectal cancer. Nichols S; Koch E; Lallemand RC; Heald RJ; Izzard L; Machin D; Mullee MA Br Med J (Clin Res Ed); 1986 Jul; 293(6539):107-10. PubMed ID: 3089411 [TBL] [Abstract][Full Text] [Related]
36. Experience with haemoccult screening in Hungary. A multicenter trial. Siba S Hepatogastroenterology; 1983 Feb; 30(1):27-9. PubMed ID: 6601046 [TBL] [Abstract][Full Text] [Related]
37. Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test. Birkenfeld S; Belfer RG; Chared M; Vilkin A; Barchana M; Lifshitz I; Fruchter D; Aronski D; Balicer R; Niv Y; Levi Z J Med Screen; 2011; 18(3):135-41. PubMed ID: 22045822 [TBL] [Abstract][Full Text] [Related]
38. Identifying and screening patients at high risk of colorectal cancer in general practice. House W; Sharp D; Sheridan E J Med Screen; 1999; 6(4):205-8. PubMed ID: 10693067 [TBL] [Abstract][Full Text] [Related]
39. Feasibility of family based screening for colorectal neoplasia: experience in one general surgical practice. Stephenson BM; Murday VA; Finan PJ; Quirke P; Dixon MF; Bishop DT Gut; 1993 Jan; 34(1):96-100. PubMed ID: 8432460 [TBL] [Abstract][Full Text] [Related]
40. Self-sampling in screening to reduce mortality from colorectal cancer: a qualitative exploration of the decision to complete a faecal occult blood test (FOBT). O'Sullivan I; Orbell S J Med Screen; 2004; 11(1):16-22. PubMed ID: 15006109 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]